Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention | Zendy

Satheesh Nair | Zendy; Farzin FathOrdoubadi | Zendy; Bernard Clarke | Zendy; Magdi ElOmar | Zendy; James Foley | Zendy; Doug Fraser | Zendy; Vaikom S. Mahadevan | Zendy; Ludwig Neyses | Zendy; Raj Khattar | Zendy; Mamas A. Mamas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention

Author(s) -

Satheesh Nair,

Farzin FathOrdoubadi,

Bernard Clarke,

Magdi ElOmar,

James Foley,

Doug Fraser,

Vaikom S. Mahadevan,

Ludwig Neyses,

Raj Khattar,

Mamas A. Mamas

Publication year - 2011

Publication title -

eurointervention

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.592

H-Index - 78

eISSN - 1969-6213

pISSN - 1774-024X

DOI - 10.4244/eijv6i8a170

Subject(s) - medicine , mace , conventional pci , percutaneous coronary intervention , cardiology , restenosis , myocardial infarction , drug eluting stent , stent , target lesion , surgery

PCI with drug eluting stents (DES) has been shown to reduce restenosis and major adverse cardiac event (MACE) rates compared to bare metal stents (BMS) in native coronary vessels, although outcomes in saphenous vein graft (SVG) lesions are less clear. We retrospectively studied 388 consecutive patients admitted to our centre for SVG PCI to assess mortality and MACE outcomes (defined as composite endpoint of all-death, stroke, myocardial infarction, stent thrombosis and target lesion (TLR)/vessel (TVR) revascularisation) associated with BMS and DES use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research